Risk factors

AbbVie (ABBV) risk factors

Item 1A of every AbbVie Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.

Open ABBV in Gloom →
AbbVie's chart, financials and news, free in your browser.Open ABBV in Gloom →
  • FY2025 10-K risk factors
    33 risks3 new1 dropped4 reworded

    Skyrizi and Rinvoq together generated approximately 42% of 2025 net revenue, concentrating performance in two products.

    Filed Feb 20, 2026
  • FY2024 10-K risk factors
    31 risks

    AbbVie's risk profile is dominated by patent expirations, generic competition, and pricing pressures on its pharmaceutical products.

    Filed Feb 14, 2025